Positive and negative spatial priming in schizophrenia

Journal of Clinical and Experimental Neuropsychology

Volumn 28, Issue 5, 2006, Pages 706-720

  Zimmermann, Mark ^a   Stark, Rudolf ^a   Kern, Georg ^a   Laiacker, Manuela ^a   Kirsch, Peter ^a   Vaitl, Dieter ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; FLUPHENAZINE; HALOPERIDOL; RISPERIDONE; ZOTEPINE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; ATTENTION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; LEARNING; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REACTION TIME; REMISSION; SCHIZOPHRENIA; SYMPTOM; TASK PERFORMANCE; ANALYSIS OF VARIANCE; ASSOCIATION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DEPTH PERCEPTION; DRUG EFFECT; FOLLOW UP; HOSPITALIZATION; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; RECEPTIVE FIELD; REFERENCE VALUE;

ADULT; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; ATTENTION; CUES; FEMALE; FIELD DEPENDENCE-INDEPENDENCE; FOLLOW-UP STUDIES; HUMANS; MALE; REACTION TIME; REFERENCE VALUES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; SPACE PERCEPTION;

EID: 33746279692     PISSN: 13803395     EISSN: 1744411X     Source Type: Journal    
DOI: 10.1080/13803390590954290     Document Type: Article

References (42)

1. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV). Washington, DC: Author.
2. Andreasen, N.C. (1989). Scale for the Assessment of Negative Symptoms (SANS). British Journal of Psychiatry, 155, 53-58.
3. Beech, A., Powell, T., McWilliam, J., & Claridge, G. (1989). Evidence of reduced "cognitive inhibition" in schizophrenia. British Journal of Clinical Psychology, 28, 109-116.
4. Bleuler, E. (1930). Primäre und sekundäre Symptome der Schizophrenie. Zeitschrift für die Gesamte Neurologie und Psychiatrie, 124, 607-646.
5. Botella, J., Barriopedro, M.I., & Joula, J.F. (2002). Temporal interactions between target and distractor processing: Positive and negative priming effects. Psicologica, 23, 371-400.
6. Braff, D.L. (1993). Information processing and attention dysfunctions in schizophrenia. Schizophrenia Bulletin, 19, 233-259.
7. Cadenhead, K.S., Geyer, M.A., Butler, R.W., Perry, W., Sprock, J., & Braff, D.L. (1997). Information processing deficits of schizophrenia patients: Relationship to clinical ratings, gender and medication status. Schizophrenia Research, 28, 51-62.
8. Callaway, E., & Naghdi, S. (1982). An information processing model for schizophrenia. Archives of General Psychiatry, 39, 339-347.
9. Chouinard, G., Jones, B., Remington, G., Bloom, D., Addington, D., MacEwan, G.W., Labelle, A., Beauclair, E., & Arnott, W. (1993). A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. Journal of Clinical Psychopharmacology, 13, 25-40.
10. Cooper, S.J., Tweed, J., Raniwalla, J., Butler, A., & Welch, C. (2000). A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia. Acta Psychiatrica Scandinavica, 101, 218-225.
11. David, A.S. (1995). Negative priming (cognitive inhibition) in psychiatric patients: Effects of neuroleptics. Journal of Nervous and Mental Disease, 183, 337-339.
12. Fox, E. (1995). Negative priming from ignored distractors in visual selection: A review. Psychonomic Bulletin & Review, 2, 145-173.
13. Fuller, R., Frith, C.D., & Jahanshahi, M. (2000). Reduced negative priming does indicate reduced cognitive inhibition in schizophrenia. Cognitive Neuropsychiatry, 5, 21-35.
14. Heinz, A., Knable, M.B., Coppola, R., Gorey, J.G., Jones, D.W., & Lee, K.S. (1998). Psychomotor slowing, negative symptoms and dopamine receptor availability - an IBZM-SPECT study in neuroleptic-treated and drug-free schizophrenic patients. Schizophrenia Research, 31, 19-26.
15. Hemsley, D.R. (1993). A simple (or simplistic?) cognitive model for schizophrenia. Behaviour Research and Therapy, 31, 633-645.
16. Hoenig, K., Hochrein, A., Mueller, D.J., & Wagner, M. (2002). Different negative priming impairments in schizophrenia and subgroups of obsessive-compulsive disorder. Psychological Medicine, 32, 459-468.
17. Jahn, T., & Mussgay, L. (1989). Die statistische Kontrolle möglicher Medikamenteneinflüsse in experimentalpsychologischen Schizophrenie-Studien: Ein Vorschlag zur Berechnung von Chlorpromazinä quivalenten. Zeitschrift für Klinische Psychologie, 18, 257-267.
18. Kay, S.R., Fiszbein, A., & Opler, L.A. (1987). The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13, 261-276.
19. Kraepelin, E. (1920). Die Erscheinungsformen des Irreseins. Zeitschrift für die Gesamte Neurologie und Psychiatrie, 62, 1-29.
20. Laplante, L., Everett, J., & Thomas, J. (1992). Inhibition through negative priming with Stroop stimuli in schizophrenia. British Journal of Clinical Psychology, 31, 307-326.
21. Logan, G.D. (1990). Repetition priming and automaticity: Common underlying mechanisms? Cognitive Psychology, 22, 1-35.
22. MacQueen, G.M., Galway, T., Goldberg, J.O., & Tipper, S.P. (2003). Impaired distractor inhibition in patients with schizophrenia on a negative priming task. Psychological Medicine, 33, 121-129.
23. May, C.P., Kane, M.J., & Hasher, L. (1995). Determinants of negative priming. Psychological Bulletin, 118, 35-54.
24. McDowd, J.M., Filion, D.L., Harris, M.J., & Braff, D.L. (1993). Sensory gating and inhibitory function in late-life schizophrenia. Schizophrenia Bulletin, 19, 733-746.
25. Minzenberg, M.J., Ober, B.A., & Vinogradov, S. (2002). Semantic priming in schizophrenia: A review and synthesis. Journal of the International Neuropsychological Society, 8, 699-720.
26. Moritz, S., Jacobsen, D., Mersmann, K., Kloss, M., & Andresen, B. (2000). Negative priming in schizophrenia: No evidence for reduced cognitive inhibition. Journal of Nervous and Mental Disease, 188, 624-627.
27. Moritz, S., Ruff, C., Wilke, U., Andresen, B., Krausz, M., & Naber, D. (2001). Negative priming in schizophrenia: Effects of masking and prime presentation time. Schizophrenia Research, 48, 291-299.
28. Moritz, S., Woodward, T.S., Küppers, D., Lausen, A., & Schickel, M. (2002). Increased automatic spreading of activation in thought-disordered schizophrenic patients. Schizophrenia Research, 59, 181-186.
29. Overall, J.E., & Gorham, D.R. (1962). The Brief Psychiatric Rating Scale (BPRS). Psychological Reports, 10, 799-812.
30. Park, J., & Kanwisher, N. (1994). Negative priming for spatial locations: Identity mismatching, not distractor inhibition. Journal of Experimental Psychology: Human Perception and Performance, 20, 613-623.
31. Park, S., Lenzenweger, M.F., Pueschel, J., & Holzman, P.S. (1996). Attentional inhibition in schizophrenia and schizotypy: A spatial negative priming study. Cognitive Neuropsychiatry, 1, 125-149.
32. Park, S., Pueschel, J., Sauter, B.H., Rentsch, M., & Hell, D. (2002). Spatial selective attention and inhibition in schizophrenia patients during acute psychosis and at 4-month follow-up. Biological Psychiatry, 51, 498-506.
33. Peters, E.R., Pickering, A.D., Kent, A., Glasper, A., Irani, M., David, A.S., Day, S., & Hemsley, D.R. (2000). The relationship between cognitive inhibition and psychotic symptoms. Journal of Abnormal Psychology, 109, 386-395.
34. Roesch-Ely, D., Spitzer, M., & Weisbrod, M. (2003). Cognitive inhibition and thought disorder in schizophrenia. Psychopathology, 36, 23-32.
35. Salo, R., Henik, A., Nordahl, T.E., & Robertson, L.C. (2002). Time course of inhibition and facilitation in patients with schizophrenia. Cognitive Neuropsychiatry, 7, 283-300.
36. Salo, R., Robertson, L.C., & Nordahl, T.E. (1996). Normal sustained effects of selective attention are absent in schizophrenic patients withdrawn from medication. Psychiatry Research, 62, 121-130.
37. Salo, R., Robertson, L.C., Nordahl, T.E., & Kraft, L.W. (1997). The effects of antipsychotic medication on sequential inhibitory processes. Journal of Abnormal Psychology, 106, 639-643.
38. Spitzer, M., Weisker, I., Winter, M., Maier, S., Hermle, L., & Maher, B.A. (1994). Semantic and phonological priming in schizophrenia. Journal of Abnormal Psychology, 103, 485-494.
39. Stuss, D.T., Toth, J.P., Franchi, D., Alexander, M.P., Tipper, S., & Craik, F.I.M. (1999). Dissociation of attentional processes in patients with focal frontal and posterior lesions. Neuropsychologia, 37, 1005-1027.
40. Tipper, S.P. (2001). Does negative priming reflect inhibitory mechanisms? A review and integration of conflicting views. Quarterly Journal of Experimental Psychology: Human Experimental Psychology, 54, 321-343.
41. Tipper, S.P., & Cranston, M. (1985). Selective attention and priming: Inhibitory and facilitatory effects of ignored primes. Quarterly Journal of Experimental Psychology: Human Experimental Psychology, 37, 591-611.
42. Vaitl, D., Lipp, O., Bauer, U., Schüler, G., Stark, R., Zimmermann, M., & Kirsch, P. (2002). Latent inhibition and schizophrenia: Pavlovian conditioning of autonomic responses. Schizophrenia Research, 55, 147-158.